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http:WHAT THIS PAPER ADDS
The literature on the safety of carotid endarterectomy (CEA) after intravenous thrombolysis (IVT) consists of
relatively small series. This study presents the ﬁrst very large registry based case controlled study on a
consecutive series of patients having CEA with or without previous IVT for acute stroke. Equally low procedure
related stroke and death rates were found in the two groups. Despite weaknesses in this study, including lack of
data on the interval from symptoms to CEA in the control group, the results support the indication that CEA can
also be performed within the recommended 2 weeks in patients having had IVT.Objective: Few studies have been published on the safety of carotid endarterectomy (CEA) after intravenous
thrombolysis (IVT). Registry reports have been recommended in order to gather large study groups.
Design: A retrospective, registry based, case controlled study on prospectively gathered data from Sweden, the
capital region of Finland, and from Denmark, including 30 days of follow up.
Methods: The study group was a consecutive series of 5526 patients who had CEA for symptomatic carotid artery
stenosis during a 4.5 year period. Among these, 202 (4%) had IVT prior to surgery, including 117 having CEA
within 14 days, and 59 within 7 days of thrombolysis. IVT as well as CEA were performed following established
guidelines. The median time from index symptom to CEA was 12 days (range 0e130, IQR 7e21).
Results: The 30 day combined stroke and death rate was 3.5% (95% CI 1.69e6.99) for those having IVT þ CEA,
4.1% (95% CI 3.46e4.39) for those having CEA without previous IVT (odds ratio 0.84 [95% CI 0.39e1.81]), 3.4%
(95% CI 1.33e8.39) for those having IVT þ CEA within 14 days, and 5.1% (95% CI 1.74e13.91) for those having
IVT þ CEA within 7 days.
Conclusion: Data on the time from symptoms to CEA in patients not having IVT, Rankin score, degree of stenosis,
and cerebral imaging were not available. Despite its weaknesses, this study reasserts that CEA can be performed
within the recommended 2 weeks of the onset of symptoms and IVT without increasing the risk of peri-operative
stroke or death. Centres and vascular registries are recommended to continue monitoring changes in patient
characteristics, lead times, and major complications after CEA in general, with a special focus on those who have
undergone a prior thrombolysis.
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Intravenous thrombolysis (IVT) has proven effective in
preventing permanent cerebral injury when applied to pa-
tients within the ﬁrst few hours of onset of an acute
ischaemic stroke: a thrombolytic agent, recombinant tissue
plasminogen activator (rtPA), is injected into a peripheral
vein with the purpose of resolving the suspected throm-
bosis of an intracerebral artery. The major complication to
IVT is intracerebral haemorrhage, occurring in 2e8% of
cases.1,2 After uncomplicated IVT, patients with a signiﬁcant
Safety of CEA After IVT for Acute Ischaemic Stroke 621internal carotid artery (ICA) stenosis may be candidates for
carotid endarterectomy (CEA).
CEA is well established as secondary stroke prevention in
patients with symptoms of cerebral or retinal ischemia
(minor stroke, transient ischaemic attack [TIA], or amaurosis
fugax) and a 50e99% stenosis (according to NASCET
criteria) of the extracranial part of the ICA.3,4 To prevent the
highest possible number of strokes, CEA should be per-
formed shortly after the index symptom.5 The risk of stroke
and death associated with CEA usually reaches 2e8%.6
Whereas some studies indicate that performing CEA very
early after the index symptom is safe, others indicate that
there may be increased risk associated with CEA performed
within 48 hours of the index symptom.7
There is limited knowledge about the effect of IVT on the
rate of complications after subsequent CEA: the literature is
scarce and consists of comparably small series (5e73 pa-
tients).8e13 Collaborative registry reports have been rec-
ommended to recruit a sufﬁciently large study group.14
Vascular registries are well established in Sweden,
Denmark, and the capital province of Finland. Thus, a
multinational population based study was initiated with the
purpose of examining the rate of complications among
patients undergoing CEA alone, and those undergoing CEA
after successful IVT for acute ischaemic stroke in a large
contemporary consecutive series of patients with a symp-
tomatic ICA stenosis.
METHODS AND PATIENTS
In this a purely register based retrospective study of pro-
spectively collected data, a consecutive series of patients
who underwent CEA for symptomatic carotid artery stenosis
during the period from May 2008 through November 2012
was reviewed. Data were collected from the national
vascular registries in Sweden (SWEDVASC15), and Denmark
(KARBASE16), and from the Finnish registry covering the
Helsinki-Uusimaa region (HUSVASC17). Supplementary in-
formation on those patients having IVT was obtained, and
data on any stroke or death after discharge from the
vascular department was obtained by extracting data from
The Swedish Stroke Registry,18 the Finnish Thrombolysis
registry,19 and Cause of Death registry,20 as well as from The
Danish Stroke Register and The National Patient Register in
Denmark.21 The vascular registries have similar structures
and data, including 30 day follow up. Data were merged
into a predeﬁned protocol for analysis. There were no
missing data from the IVT þ CEA group. The outcome data
were crossmatched with the other registries.
Ethical approval was obtained from the ethical review
boards of each nation.Organisation
In Sweden (9.5 million inhabitants e 2012), management of
patients with acute cerebral ischaemic events varies across
the country depending on regional structures. In 2012, 72%
were admitted to stroke units (departments with neuro-
logical expertise).22 All regional, most county, and somedistrict hospitals offer IVT at all hours. In 2012, approxi-
mately 12% of all patients with an acute ischaemic stroke
were treated with IVT.22 Carotid artery surgery is centralised
to seven regional and 14 county hospitals. In the Helsinki-
Uusimaa region of Finland (1.5 million inhabitants e
2012), all patients with suspected acute ischaemic stroke
and eligible for IVT are transferred to the stroke unit at
Helsinki University Central Hospital (HUCH) where IVT is
available at all hours. In 2011, 31% were treated with
IVT23,24. The department of vascular surgery is located at
the same hospital. In Denmark (5.6 million inhabitants e
2012), 95% of all patients with symptoms of acute ischae-
mic stroke are admitted or transferred within the ﬁrst 48
hours to the nearest stroke unit.25 IVT is offered at all hours
at selected centres in major cities. Twelve per cent of pa-
tients with acute ischaemic stroke are treated with IVT.25
Vascular surgery is centralized to seven centres, not al-
ways located in the same hospital as the stroke unit.Intravenous thrombolysis
IVT was given in accordance with internationally accepted
guidelines: patients should present signs of acute stroke,
cerebral imaging should exclude haemorrhage, IVT must be
started within 4.5 hours of onset of symptoms, and the
patient’s previous level of function must have been good. A
dose of 0.9 mg alteplase per kg bodyweight (concentration:
1 mg mL1) was injected in a peripheral vein (10% as a
bolus during 1e2 min, and the rest during the following
hour). All patients received antiplatelet therapy after 24
hours.26,27Carotid endarterectomy
CEA was offered in accordance with internationally
accepted guidelines to patients with symptomatic 50e99%
stenosis (NASCET criteria) in all three countries.5,6 Anti-
platelet therapy was continued without interruption. Oral
anticoagulants (warfarin) were discontinued if possible for
1e2 days prior to CEA to 1 day after CEA, and replaced with
low-molecular-weight heparin (LMWH). Blood pressure was
stabilised pre-operatively and monitored continuously per-
operatively, and kept within 20% of the pre-operative
level depending on the degree of stenosis. CEA was per-
formed under either local or general anaesthesia. Cerebral
perfusion during CEA was monitored using locally preferred
techniques: transcranial Doppler (TCD) or Near Infrared
Spectroscopy (NIRS). Some preferred stump pressure for
indirect evaluation of the cerebral perfusion during cross-
clamping. A carotid shunt was used according to the centre/
surgeon’s algorithm. Patients were observed in post-
operative recovery units with continuous intra-arterial
blood pressure monitoring and neurological evaluation.
When stable, patients were transferred to the vascular
ward. To meet the risk of developing hyperperfusion,
elevated blood pressure was lowered as was performed
prior to the operation. If no complication was observed,
patients were discharged after 1e2 days. Thirty days after
Table 1. Age and gender of patients having and not having
intravenous thrombolysis (IVT) prior to carotid endarterectomy
(CEA) (number (per cent)).
CEA þ IVT N Gender, N (%) Age, years
Female Male Median
622 L.K. Rathenborg et al.CEA, patients were examined by a neurologist, a stroke
physician, a vascular surgeon, or (in Helsinki) a nurse.
As IVT is performed within few hours of the onset of
symptoms, the time to CEA is calculated from the day at
which IVT was initiated.(minemax)
Sweden 73 23 (32) 50 (68) 72 (38e84)
Finland 38 20 (53) 18 (47) 69 (50e88)
Denmark 91 22 (24) 69 (76) 71 (52e85)
Total 202 65 (32) 137 (68) 71 (38e88)
CEA alone N Gender, N (%) Age, years
Female Male Median
(minemax)
Sweden 2990 981 (33) 2009 (67) 74 (41e93)
Finland 626 259 (41) 367 (59) 71 (34e90)
Denmark 1708 567 (33) 1141 (67) 69 (35e93)
Total 5324 1807 (34) 3517 (66) 72 (34e93)Statistics
Statistical analysis was performed using the Statistical
Package for Social Sciences, software version 21.0 (SPSS,
Chicago, IL, USA). Dichotomic variables were expressed as
number of cases and percentages and compared using chi-
square test. Continuous variables are expressed as median
values  SD (range) and interquartile range (IQR) and were
compared using the Student t test.
Any p values of <0.01 were considered signiﬁcant,
adjusting for multiple comparisons.
RESULTS
From May 2008 through November 2012 a consecutive
series of 6630 patients with a symptomatic carotid stenosis
was included in this investigation. To increase the compa-
rability of groups, 1097 patients who had CEA following
amaurosis fugax (which is not an indication for IVT) were
excluded. Another seven patients from the Faroe Islands,
having CEA in Denmark, were lost to follow-up, leaving 5526
patients available for study: 3064 from Sweden, 664 from
Finland (Helsinki-Uusimaa region), and 1798 from Denmark.
Among these, 202 patients (4%) had IVT prior to CEA
(IVT þ CEA) while 5324 patients (96%) had CEA without
previous IVT (CEA alone). The percentage of patients having
IVT þ CEA was signiﬁcantly higher in Helsinki (5.0%) and in
Denmark (4.4%) compared with Sweden (2.0%) (p < 0.001).
The median time from IVT to CEA was 12 days (range 0e
130, IQR 7e21), Sweden 10 days (range 1e130), Finland 7
days (range 0e89), and Denmark 15 days (range 2e85)
(Sweden vs. Finland: p ¼ 0.26; Sweden vs. Denmark:
p ¼ 0.40; Finland vs. Denmark: p ¼ 0.51).
CEA was performed within 14 days of IVT in 177 patients
(median 7 days [range 0e14]). Among these, 59 had CEA
within 7 days of IVT (median 4 days [range 0e7]).
Information on the time from index symptom to CEA in
those not having IVT was not available.
The stroke rate was 3.5% (95% CI 1.69e6.99) among
patients having IVT þ CEA, 3.4% (95% CI 1.33e8.39) among
those having CEA within 14 days, and 5.1% (95% CI 1.74e
13.91) among those having CEA within 7 days. No patients
from these groups died within the ﬁrst 30 days. Among the
seven patients who suffered a stroke within 30 days of CEA,
the time from IVT to CEA was the same as in the whole
cohort: median 12 days (range 6e21, p ¼ 0.10). The com-
bined stroke and death rate was 4.1% (95% CI 3.59e0.46)
among those having CEA without previous IVT. The odds
ratio for the stroke and death rate for the IVT þ CEA group
compared with the CEA alone group was 0.84 (95% CI
0.39e1.81).
The distribution of age and sex between the countries,
and for the two groups (IVT þ CEA and CEA alone), arepresented in Table 1. There was no difference in age and
sex distribution between the patients who underwent
IVT þ CEA and those who underwent CEA alone (p ¼ 0.03).
Among those who underwent IVT þ CEA, the proportion of
females was higher in Finland (than in Denmark) (Finland
vs. Sweden: p ¼ 0.03; Finland vs. Denmark: p ¼ 0.002). This
was also true among those who underwent CEA alone,
although the numerical difference was smaller (Finland vs.
Sweden: p < 0.0001; Finland vs. Denmark: p ¼ 0.0003).
Further characteristics including comorbidity (diabetes,
hypertension, heart disease, and smoking habits) are listed
in Table 2. There was no difference in the prevalence of
comorbidity between the total group of IVT þ CEA patients
and the CEA alone patients.
Among the IVT þ CEA patients, the prevalence of dia-
betes was lower in Denmark (Denmark vs. Sweden:
p ¼ 0.001; Denmark vs. Finland: p ¼ 0.005). There were no
differences between the three nations regarding the prev-
alence of heart disease or smoking habits. Among the CEA
alone patients, the prevalence of diabetes and heart dis-
ease, as well as the proportion of current smokers was
signiﬁcantly lower in Denmark than in Sweden (p ¼ 0.006,
p < 0.0001, and p < 0.0001, respectively).
The symptom leading to IVT was deﬁned as stroke in all
patients even though symptoms may resolve within 24
hours e similar to the deﬁnition of a transient ischaemic
attack (TIA). The index symptoms among patients having
CEA alone are listed in Table 3.
Speciﬁc information on the degree of stenosis, disability
before and after CEA (e.g. modiﬁed Rankin score), and on
the nature of antiplatelet therapy in each patient was not
available for this study.
DISCUSSION
The main ﬁnding of this multinational registry study was
that there was no difference regarding the 30 days com-
bined stroke and death rate following carotid endarterec-
tomy comparing patients who underwent IVT prior to CEA
with those who underwent CEA alone. Among the 117
patients having CEA within 14 days of IVT, and in those
Table 4. Stroke and death rates after IVT and CEA reported from
Table 2. Comorbidity among patients having and not having intravenous thrombolysis (IVT) prior to carotid endarterectomy (CEA) (number
(per cent)).
DMa Hypertensionb Heart diseasec Active smoking
IVT D CEA
Sweden 18 (27)
(N ¼ 66)
56 (84)
(N ¼ 67)
18 (28)
(N ¼ 64)
13 (25)
(N ¼ 52)
Finland 9 (29)
(N ¼ 31)
28 (88)
(N ¼ 32)
12 (29)
(N ¼ 31)
13 (42)
(N ¼ 31)
Denmark 8 (9)
(N ¼ 91)
61 (68)
(N ¼ 90)
27 (30)
(N ¼ 90)
25 (28)
(N ¼ 28)
Total 35 (19)
(N [ 188)
145 (77)
(N [ 77)
57 (31)
(N [ 185)
51 (30)
(N [ 171)
CEA alone
Sweden 583 (21)
(N ¼ 2792)
1756 (61)
(N ¼ 2868)
834 (30)
(N ¼ 2756)
565 (24)
(N ¼ 2354)
Finland 175 (29)
(N ¼ 599)
486 (84)
(N ¼ 578)
564 (44)
(N ¼ 597)
194 (31)
(N ¼ 630)
Denmark 285 (17)
(N ¼ 1701)
1234 (73)
(N ¼ 1698)
442 (26)
(N ¼ 1695)
668 (40)
(N ¼ 1686)
Total 1043 (20)
(N [ 5094)
3972 (77)
(N [ 5129)
1537 (30)
(N [ 5051)
1427 (31)
(N [ 4583)
a Medically treated diabetes (type I or II).
b Medically treated hypertension in any form.
c Coronary artery and/or congestive heart disease (medically or surgically treated including endovascular treatment).
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similarly low. The rate of complications for the IVT þ CEA
group in the present study is similar to the pooled outcome
from previously reported series (3.1%) (Table 4).8e13
It could be argued that patients with TIAs should be
excluded from the control group. However, it has been
shown that, despite full remission within 24 hours, signs of
cerebral infarction on cerebral magnetic resonance imaging
(MRI) can be seen in 30e50% of TIA patients, and revision
of the time dependent deﬁnition of TIA was suggested by
the American Heart Association in 2009.28 In the present
study, the “old” deﬁnition of TIA (symptoms lasting less
than 24 hours) was used, and information on the duration
of symptoms was not available nor was data on cerebral
imaging. Therefore, all patients with cerebral ischaemic
symptoms were included in the control group.
The characteristics in terms of age, gender, smoking
habits, and comorbidity of the patients in the two groups,
IVT þ CEA and CEA alone, were comparable. There were
some differences in basic characteristics between the
countries: ﬁrstly, there was a larger proportion of female
patients in Finland. This may be associated with a somewhat
shorter interval from symptom to CEA among the FinnishTable 3. Index symptom (number (per cent)) among 5324 patients
having carotid endarterectomy without previous intravenous
thrombolysis.
TIA, n (%) Stroke, n (%) Total, n (%)
Sweden 1635 (55) 1356 (45) 2991 (100)
Finland 345 (55) 281 (45) 626 (100)
Denmark 900 (53) 807 (47) 1347 (100)
Total 2880 (54) 2444 (46) 5324 (100)patients: because the beneﬁt of CEA has been shown to
decrease more rapidly with time in women than men, the
longer the delay, the fewer women beneﬁt from CEA, and
thus fewer are offered surgery.5 Secondly, the proportion of
patients with diabetes was signiﬁcantly lower in Denmark
and the proportions of smokers, diabetics, and patients with
heart disease were signiﬁcantly lower in Denmark
compared with Sweden. Most likely, these differences
reﬂect difﬁculties in gathering true risk factor/comorbidity
data in registries. Contrary to data on stroke and deaths,
where crosschecking of data is possible, it was not possible
to validate data on comorbidity in the same way, and
therefore these data are less robust.
The organisation of, and guidelines for, treatment with
IVT, as well as CEA, were more or less the same within the
three nations. The time from IVT to CEA was less than 20
days in 75% of patients. During the studied period, initia-
tives were taken in all three countries to minimize the in-
terval. In consequence, the overall interval from the index
symptom to CEA reached a median of 7 days in Sweden in
2012 (IQR 4e13).15 In Helsinki, the interval decreasedthe earlier case series.
Number of
patients
30-day stroke
and death (%)
McPherson9 5 0
Bartoli10 12 8.3
Crozier13 10 0
Rathenborg8 22 14
Yong11 7 2.7
Koraen-Smith12 73 3.1
Total 129 3.1
624 L.K. Rathenborg et al.similarly.24 In Denmark in 2012, 61% of all CEAs were per-
formed within 14 days (from admission to a hospital with
symptoms of cerebral ischemia); in the capital region the
proportion reached 89%.25 Presuming that a similar pattern
is seen in Sweden and Finland, it is not surprising that, in
this study, the IVT to CEA interval was a little shorter among
the Finnish patients compared with the Swedish and Danish
patients, reﬂecting that the Finnish catchment area was
restricted to the capital area. The differences in timing of
CEA, however, were not signiﬁcant. Nevertheless, this is a
potential confounder when comparing the three countries.
Unfortunately, data on the length of the interval from the
index symptom to CEA in the group of patients having CEA
alone were not available from all registries. In a previous
study, Rathenborg et al.8 reported a median delay for
IVT þ CEA patients of 11 days and 12 days for CEA alone
patients. Koraen-Smith et al.12 reported an interval from
index symptom to either CEA or carotid artery stenting
(CAS) of 10 days for the IVT þ CEA/CAS group and 9 days for
the CEA/CAS alone group among a similar cohort of
Swedvasc patients to those in this study. The authors of the
present study have no reason to believe that the timing of
CEA without IVT should be any different from the timing of
CEA after IVT in our study. Although the lack of a uniform
deﬁnition of the term “index symptom”, as indicated by den
Hartog et al.29 may weaken the validity of results, it is
acknowledged that the incomplete data on timing of CEA
among those patients not having IVT is a limitation in the
present study.
As indicated by Fassbender et al.,30 even though the half
life of the thrombolytic agent reaches only 3e5 minutes,
IVT has been shown to induce a widespread response of
markers of coagulation activation and ﬁbrin formation,
persisting up to 72 hours. In addition, Vivien et al.31 indi-
cated that rtPA may exacerbate a hyperperfusion injury by
facilitating the opening of the bloodebrain barrier, pro-
moting kainite induced neurotoxicity, and activating several
inﬂammatory mediators and metalloproteinases that play a
central role in the development of parenchymal haemor-
rhages. On the other hand, the beneﬁcial effects of IVT on
restoring perfusion and salvaging ischaemic brain tissue
outweigh the potential drawbacks if given within the
accepted 4.5 hour window. Among others, Rha et al.32 have
emphasized, that after an acute stroke, the strongest pre-
dictor of good clinical outcome is early recanalization. Thus,
IVT may restore perfusion and therefore actually reduce the
risk of complications following subsequent CEA.
The previous literature on this subject consists of studies
on small series and registry reports have recommended
larger series. Although this study presents a large consec-
utive series of patients all having carotid endarterectomy
for symptomatic carotid stenoses, the percentage of pa-
tients having had IVT prior to surgery was only 4%. An
increasing proportion of patients undergoing pre-operative
IVT may be expected in the future, as it is becoming routine
treatment in an increasing number of stroke units.
Furthermore, the interval from index symptom to initiation
of IVT is expanding, and the exclusion criteria are becomingfewer. If, as recommended, more patients with symptomatic
ICA stenoses are offered CEA, the number of patients having
both procedures will increase over time.
In conclusion, given the limitations presented above, the
present study supports the indication that carotid endar-
terectomy can be performed within the recommended 2
weeks of onset of symptoms and thrombolysis without
increasing the risk of peri-operative stroke or death. Centres
performing CEA and vascular registries are recommended to
continue monitoring changes in patient characteristics, lead
times, and major complications after carotid endarterec-
tomy in general, with special focus on those who have
undergone a prior thrombolysis.CONFLICT OF INTEREST
None.FUNDING
None.REFERENCES
1 Wahlgren N, Ahmed N, Dàvalos A, Ford GA, Grond M, Hacke W,
et al. Thrombolysis with alteplase for acute stroke in the safe
implementation of thrombolysis in stroke-monitoring study
(SITS-MOST): an observational study. Lancet 2007;27:275e82.
2 Wechsler LR. Intravenous thrombolytic therapy for acute
ischemic stroke. N Engl J Med 2011;22:2138e46.
3 North American Symptomatic Carotid Endarterectomy Trial
Collaborators. Beneﬁcial effect of carotid endarterectomy in
patients with high-grade stenosis. N Engl J Med 1991;325:445e
53.
4 European Carotid Surgical Trialist Group. MRC European ca-
rotid surgical trial: interim results for symptomatic patients
with severe (80e99%) or mild (0e29%) carotid stenosis. Lancet
1991;337:1235e43.
5 Rothwell PM, Eliasziew M, Gutnikov SA, Warlow CP, Barnett H.
Carotid Endarterectomy Trialist Collaboration. Endarterectomy
for symptomatic carotid stenosis in relation to clinical sub-
groups and timing of surgery. Lancet 2004;363:915e24.
6 Liapis CD, Bell PF, Mikhailidis D, Sivenius J, Nicholaides A,
Fernandes e Fernandes J, et al. On behalf of the ESVS Guideline
Collaborators. ESVS guidelines, invasive treatment for carotid
stenosis: indications, techniques. Eur J Vasc Endovasc Surg
2009;37:1e19.
7 Stromberg S, Gelin J, Osterberg T, Bergstrom GML, Karlstrom L,
Osterberg K. Very urgent carotid endarterectomy confers
increased procedural risk. Stroke 2012;43:1331e5.
8 Rathenborg LK, Jensen LP, Baekgaard N. Carotid endarterec-
tomy after intravenous thrombolysis for acute cerebral
ischaemic attack: is it safe? Eur J Vasc Endovasc Surg
2013;45(6):573e7.
9 McPherson CM, Woo D, Cohen PL, Pancioli AM, Kissela BM,
Carrozzella JA, et al. Early carotid endarterectomy for critical
carotid artery stenosis after thrombolysis in acute stroke in the
middle cerebral artery. Stroke 2001;31:2075e80.
10 Bartoli MA, Squarcioni C, Nicoli F, Magnaa PE, Malikov S,
Berger L, et al. Early carotid endarterectomy after intravenous
thrombolysis for acute stroke. Eur J Vasc Endovasc Surg
2009;37:512e8.
Safety of CEA After IVT for Acute Ischaemic Stroke 62511 Yong YP, Saunders J, Abisi S, Sprigg N, Varadhan K,
MacSweeney S, et al. Safety of carotid endarterectomy
following thrombolysis for acute ischemic stroke. J Vasc Surg
2013;58:1671e7.
12 Koraen-Smith L, Troeng T, Björck M, Kragsterman B,
Wahlgren CM. Urgent carotid surgery and stenting may be safe
after systemic thrombolysis for stroke. Stroke 2014;45:776e80.
13 Crozier CEM, Reid J, Welch GH, Muir KW, Stuart WP. Early
endarterectomy following thrombolysis in the hyperacute
treatment of stroke. Br J Surg 2011;98:235e8.
14 Padberg Jr F. Role of carotid endarterectomy following intra-
venous thrombolysis. Eur J Vasc Endovasc Surg 2013;45:578.
15 The Swedish Vascular Registry. SWEDVASC. www.swedvasc.se.
16 The Danish Vascular Registry. Annual report 2012. www.
karbase.dk; 2014-27-03.
17 Taha AG, Vikatmaa P, Albäck A, Aho PS, Railo M, Lepäntalo M.
Are adverse events after carotid endarterectomy reported
comparable in different registries? Eur J Vasc Endovasc Surg
2008;35:280e5.
18 The Swedish Stroke Registry. http://www.riks-stroke.org.
19 Meretoja A, Putaala J, Tatlisumak T, Atula S, Artto V, Curtze S,
et al. Off-label thrombolysis is not associated with poor
outcome in patients with stroke. Stroke 2010;41:1450e8.
20 The Finnish Cause of Death Registry. http://www.stat.ﬁ/til/
kuol/index_en.html.
21 Wildenschild C, Mehnert F, Thomsen RW, Iversen HK,
Vestergaard K, Ingeman A, et al. Registration of acute stroke:
validity in the Danish Stroke Registry and the Danish National
Registry of Patients. Clin Epidemiol 2014;6:27e36.
22 The Swedish Stroke Registry (Riks-Stroke). Annual report 2012.
http://www.riks-stroke.org/content/analyser/Riks-Strokes_
Arsrapport 2012.pdf.
23 Meretoja A, Strbian D, Mustanoja S, Tatlisumak T, Lindsberg PJ,
Kaste M. Reducing in-hospital delay to 20 minutes in stroke
thrombolysis. Neurology 2012;79(4):306e13.24 Noronen K, Vikatmaa P, Sairanen T, Lepäntalo M, Venermo M.
Decreasing the delay to carotid endarterectomy in symptom-
atic patients with carotid stenosis e outcome of an interven-
tion. Eur J Vasc Endovasc Surg 2012;44:261e6.
25 The Danish Stroke Registry. Annual report 2012. https://www.
sundhed.dk/content/cms/69/4669_dansk-apopleksi-registerrs
rapport-2012ﬁnal-v1115042013.pdf.
26 Jauch EC, Saver JL, Adams Jr HP, Bruno A, Connors JJ,
Demaerschalk BM, et al. American Heart Association Stroke
Council on Clinical Cardiology. Guidelines for the early man-
agement of patients with acute ischemic stroke: a guideline for
healthcare professionals from the American Heart Association/
American Stroke Association. Stroke 2013;44:870e947.
27 Mishra NK, Ahmed N, Andersen G, Egido JA, Lindberg PJ,
Ringleb PA, et al. Thrombolysis in very elderly people: controlled
comparison of SITS international stroke thrombolysis registry
and virtual internal trialists archive. Br Med J 2010;23:341e5.
28 Easton JD, Saver LJ, Albers GW, Alberts MJ, Chaturvedi S,
Feldmann E, et al. Deﬁnition and evaluation of transient
ischemic attack: a scientiﬁc statement for healthcare pro-
fessionals. Stroke 2009;40:2276e93.
29 den Hartog AG, Moll FL, van der Worp HB, Hoff RG, Kappelle LJ,
de Borst GJ. Delay to carotid endarterectomy in patients with
symptomatic carotid artery stenosis. Eur J Vasc Endovasc Surg
2014;47:233e9.
30 Fassbender K, Dempﬂe CE,MielkeO, Schwartz A, DaffertshoferM,
Eschenfelder C, et al. Changes in coagulation and ﬁbrinolysis
markers in acute ischemic stroke treated with recombinant tissue
plasminogen activator. Stroke 1999;30:2101e4.
31 Vivien D, Gauberti M, Motagne A, Defer G, Touzé E. Impact of
tissue plasminogen activator on the neurovascular unit: from
clinical data to experimental evidence. J Cereb Blood Flow
Metab 2011;31:2119e34.
32 Rha JH, Saver JL. The impact of recanalization on ischemic
stroke outcome: a metaanalysis. Stroke 2007;38:967e73.
